Su An

Dictamnine, a novel c-Met inhibitor, suppresses the proliferation of lung cancer cells by downregulating the PI3K/AKT/mTOR and MAPK signaling pathways

Jiaojiao Yu, Lijing Zhang, Jun Peng et al. · Biochemical Pharmacology · 2021 · 65 citations · Full text

A novel family of RGD-containing disintegrins (Tablysin-15) from the salivary gland of the horsefly Tabanus yao targets αIIbβ3 or αVβ3 and inhibits platelet aggregation and angiogenesis

Huan Liu, Xuening Yang, John F. Andersen et al. · Thrombosis and Haemostasis · 2011 · 62 citations · Full text

Regulation of Proinflammatory Mediators via NF-<i>κ</i>B and p38 MAPK-Dependent Mechanisms in RAW 264.7 Macrophages by Polyphenol Components Isolated from Korea<i>Lonicera japonica THUNB</i>

Kwang‐Il Park, Sang‐Rim Kang, Hyeon‐Soo Park et al. · Evidence-based Complementary and Alternative Medicine · 2012 · 54 citations · Full text

IRS4 promotes the progression of non-small cell lung cancer and confers resistance to EGFR-TKI through the activation of PI3K/Akt and Ras-MAPK pathways

Peiqi Hao, Ying Huang, Jun Peng et al. · Experimental Cell Research · 2021 · 27 citations

Medicine, Receptor Tyrosine Kinase, Ras-mapk Pathways +7

KAP1 inhibits the Raf‐MEK‐ERK pathway to promote tumorigenesis in A549 lung cancer cells

Jun Pen, Ying Huang, Su An et al. · Molecular Carcinogenesis · 2018 · 23 citations

Cancer Biology, Tumor Biology, Receptor Tyrosine Kinase +17